pantoprazole and pentagastrin

pantoprazole has been researched along with pentagastrin in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's6 (54.55)18.2507
2000's2 (18.18)29.6817
2010's3 (27.27)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Bliesath, H; Hartmann, M; Lühmann, R; Müller, P; Schneider, A; Simon, B; Wurst, W1
Bräuer, U; Kromer, W; Postius, S1
Bliesath, H; Hartmann, M; Huber, R; Lühmann, R; Müller, P; Simon, B; Wurst, W1
Hartmann, R; Huber, R; Lühmann, R; Marinis, E; Müller, P; Simon, B; Wurst, W1
Bliesath, H; Bohnenkamp, W; Hartmann, M; Huber, R; Lühmann, R; Müller, P; Simon, B; Wurst, W1
Martin, P; McKeand, W; Ohning, G; Paul, J; Pisegna, JR; Walsh, JH1
Bochenek, WJ; Ferron, GM; Metz, DC; Paul, J; Pisegna, JR; Soffer, E; Turner, MB1
Burton, MS; Hogan, DL; Karlstadt, RG; Lane, JR; Lynn, RB; Pratha, VS; Williams, PJ1
Ahangarpour, A; Gharib-Naseri, MK; Mard, SA; Veisi, A1

Reviews

1 review(s) available for pantoprazole and pentagastrin

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

5 trial(s) available for pantoprazole and pentagastrin

ArticleYear
Reduction of pentagastrin stimulated acid output: a suitable method to predict efficacy of an irreversible proton pump inhibitor in peptic ulcer disease?
    International journal of clinical pharmacology, therapy, and toxicology, 1992, Volume: 30, Issue:11

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Duodenal Ulcer; Gastric Acid; Humans; Injections, Intravenous; Male; Omeprazole; Pantoprazole; Pentagastrin; Proton Pump Inhibitors; Proton Pumps; Single-Blind Method; Sulfoxides

1992
Effect of repeated oral administration of BY 1023/SK&F 96022--a new substituted benzimidazole derivative--on pentagastrin-stimulated gastric acid secretion and pharmacokinetics in man.
    Alimentary pharmacology & therapeutics, 1990, Volume: 4, Issue:4

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Adult; Benzimidazoles; Blood Pressure; Gastric Acid; Gastrins; Half-Life; Heart Rate; Humans; Hydrogen-Ion Concentration; Male; Omeprazole; Pantoprazole; Pentagastrin; Sulfoxides

1990
Inhibition of pentagastrin-induced gastric acid secretion by intravenous pantoprazole: a dose-response study.
    The American journal of gastroenterology, 1999, Volume: 94, Issue:10

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Anti-Ulcer Agents; Benzimidazoles; Dose-Response Relationship, Drug; Famotidine; Female; Gastric Acid; Humans; Infusions, Intravenous; Male; Middle Aged; Omeprazole; Pantoprazole; Pentagastrin; Proton Pump Inhibitors; Sulfoxides; Zollinger-Ellison Syndrome

1999
Proton pump activation in stimulated parietal cells is regulated by gastric acid secretory capacity: a human study.
    Journal of clinical pharmacology, 2002, Volume: 42, Issue:5

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Dose-Response Relationship, Drug; Female; Gastric Acid; Humans; Male; Omeprazole; Pantoprazole; Parietal Cells, Gastric; Pentagastrin; Proton Pumps; Sulfoxides; Time Factors

2002
Inhibition of pentagastrin-stimulated gastric acid secretion by pantoprazole and omeprazole in healthy adults.
    Digestive diseases and sciences, 2006, Volume: 51, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Female; Follow-Up Studies; Gastric Acid; Gastric Acidity Determination; Gastric Mucosa; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Omeprazole; Pantoprazole; Pentagastrin; Prospective Studies; Proton Pump Inhibitors; Reference Values; Stomach; Sulfoxides

2006

Other Studies

5 other study(ies) available for pantoprazole and pentagastrin

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
The novel proton pump inhibitor pantoprazole elevates intragastric pH for a prolonged period when administered under conditions of stimulated gastric acid secretion in the gastric fistula dog.
    Life sciences, 1991, Volume: 49, Issue:14

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Animals; Benzimidazoles; Dogs; Famotidine; Gastric Acid; Gastric Fistula; Gastric Mucosa; Male; Omeprazole; Pantoprazole; Pentagastrin; Stomach; Sulfoxides

1991
Single intravenous administration of the H+, K(+)-ATPase inhibitor BY 1023/SK&F 96022--inhibition of pentagastrin-stimulated gastric acid secretion and pharmacokinetics in man.
    Alimentary pharmacology & therapeutics, 1990, Volume: 4, Issue:3

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Adult; Benzimidazoles; Dose-Response Relationship, Drug; Electrocardiography; Gastric Acid; Gastric Juice; H(+)-K(+)-Exchanging ATPase; Half-Life; Humans; Injections, Intravenous; Male; Omeprazole; Pantoprazole; Pentagastrin; Single-Blind Method; Sulfoxides

1990
Pentagastrin-stimulated gastric acid secretion and pharmacokinetics following single and repeated intravenous administration of the gastric H+, K(+)-ATPase-inhibitor pantoprazole (BY1023/SK&F96022) in healthy volunteers.
    Zeitschrift fur Gastroenterologie, 1990, Volume: 28, Issue:9

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Benzimidazoles; Gastric Acid; Gastrins; Humans; Hydrogen-Ion Concentration; Male; Omeprazole; Pantoprazole; Pentagastrin; Single-Blind Method; Sodium-Potassium-Exchanging ATPase; Sulfoxides

1990
Gastric acid induces mucosal H2S release in rats by upregulating mRNA and protein expression of cystathionine gamma lyase.
    The journal of physiological sciences : JPS, 2015, Volume: 65, Issue:6

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Alcohols; Animals; Anti-Ulcer Agents; Cystathionine beta-Synthase; Cystathionine gamma-Lyase; Gastric Acid; Gastric Mucosa; Gene Expression Regulation; Gene Expression Regulation, Enzymologic; Hydrogen Sulfide; Male; Nitric Oxide; Nitric Oxide Synthase Type III; Pantoprazole; Pentagastrin; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; RNA, Messenger; Up-Regulation

2015